These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32440298)

  • 1. Serum Procalcitonin Level as a Predictor of Bacterial Infection in Patients with COPD Exacerbation.
    Abedini A; Kiani A; Emami H; Touhidi MH
    Tanaffos; 2019 Feb; 18(2):112-117. PubMed ID: 32440298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
    Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.
    Falsey AR; Becker KL; Swinburne AJ; Nylen ES; Snider RH; Formica MA; Hennessey PA; Criddle MM; Peterson DR; Walsh EE
    Int J Chron Obstruct Pulmon Dis; 2012; 7():127-35. PubMed ID: 22399852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens.
    Kawamatawong T; Apiwattanaporn A; Siricharoonwong W
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1625-1630. PubMed ID: 28615935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of serum procalcitonin in diagnosing bacterial lower respiratory tract infections in people with exacerbation of Chronic Obstructive Pulmonary Disease].
    Chang C; Yao WZ; Chen YH; Liu ZY; Zhang XW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):389-92. PubMed ID: 16892144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin and CRP as Biomarkers in Discrimination of Community-acquired Pneumonia and Exacerbation of COPD.
    Çolak A; Yılmaz C; Toprak B; Aktoğu S
    J Med Biochem; 2017 Apr; 36(2):122-126. PubMed ID: 28680355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum procalcitonin levels in chronic obstructive pulmonary disease patients in North Indian Population.
    Pandey S; Garg R; Kant S; Verma A; Gaur P
    Ann Afr Med; 2019; 18(2):103-107. PubMed ID: 31070153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The changes and clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease].
    Chang C; Yao WZ; Chen YH; Liu ZY; Zhang XW
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jul; 29(7):444-7. PubMed ID: 17045042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic stone protein predicts positive sputum bacteriology in exacerbations of COPD.
    Scherr A; Graf R; Bain M; Christ-Crain M; Müller B; Tamm M; Stolz D
    Chest; 2013 Feb; 143(2):379-387. PubMed ID: 22922487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
    Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
    Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
    Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
    Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.
    Papi A; Bellettato CM; Braccioni F; Romagnoli M; Casolari P; Caramori G; Fabbri LM; Johnston SL
    Am J Respir Crit Care Med; 2006 May; 173(10):1114-21. PubMed ID: 16484677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.
    Aaron SD; Angel JB; Lunau M; Wright K; Fex C; Le Saux N; Dales RE
    Am J Respir Crit Care Med; 2001 Feb; 163(2):349-55. PubMed ID: 11179105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation.
    Bathoorn E; Liesker JJ; Postma DS; Koëter GH; van der Toorn M; van der Heide S; Ross HA; van Oosterhout AJ; Kerstjens HA
    Int J Chron Obstruct Pulmon Dis; 2009; 4():101-9. PubMed ID: 19436694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The levels of serum pro-calcitonin and high-sensitivity C-reactive protein in the early diagnosis of chronic obstructive pulmonary disease during acute exacerbation.
    Gao D; Chen X; Wu H; Wei H; Wu J
    Exp Ther Med; 2017 Jul; 14(1):193-198. PubMed ID: 28672914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Values of procalcitonin and C-reactive proteins in the diagnosis and treatment of chronic obstructive pulmonary disease having concomitant bacterial infection.
    Li Y; Xie L; Xin S; Li K
    Pak J Med Sci; 2017; 33(3):566-569. PubMed ID: 28811772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
    Daubin C; Parienti JJ; Vabret A; Ramakers M; Fradin S; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
    BMC Infect Dis; 2008 Oct; 8():145. PubMed ID: 18947382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
    Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
    Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.